Project description DEENESFRITPL Making vision treatment child’s play As many as 5 % of children today undergo vision therapy to avoid danger of reduced vision or even loss of sight. The most common children’s problems are crossed eye (strabismus) or lazy eye (amblyopia). This means children need to undergo a long, costly treatment that creates many difficulties for young patients and their families. The EU-funded PLUTO project will develop and commercialise the RemmedVR system designed by paediatric ophthalmologists. It is based on unique tracking sensors combined with virtual reality and is designed to be used at home. It’s engaging for children, turning exercises into a game. Enabling remote adjustment of exercises by a doctor through the online panel makes RemmedVR therapy significantly shorter and cheaper than other existing solutions. Show the project objective Hide the project objective Objective Strabismus (crossed eyes) and ambylopathy (lazy eye) are among the most common eye problems in children, affecting up to 5% of the population. Untreated, they may lead to reduced vision in one/both eyes or even complete loss of sight. Despite the treatment methods offered currently by medicine (surgery, eye patch, stationary vision therapy), the need to of cheap and enjoyable treatment for home use that would significantly shorten therapy time and have sufficient effectiveness has not been fulfilled.At RemmedVR, in collaboration with doctors with outstanding achievements in pediatric ophthalmology from Poland and the EU we took the challenge to create a unique world’s first system designed for remote home use, reducing therapy time from six months to 90 days on average, with minimized doctor visits while eliminating psychosocial impact on the child. RemmedVR’s tracking sensors are also unique among available vision therapies. Advanced motion tracking system makes the perception of virtual reality (VR) environment more natural and comfortable to train visual perception with games designed to stimulate the cerebral cortex for neuropathic stimulation.Considering costs of treatment and shorter therapy duration, RemmedVR is available for at least half the price of standard vision therapy and 4 times cheaper than our competitors. It also allows doctors to attend more patients and increase income.The primary objective of the Phase 2 project is to adopt virtual reality-based technology to optometry needs. Our value proposition is based on objective measurement which can be done only through tailor-made eye tracking and hand tracking sensors. Having a batch of representative prototypes, we have started proving the effectiveness of our system in pre-clinical trials. We further want to test our system in full clinical trials. Other steps covered in this project are related to scaling business and implementation of commercialization plan. Fields of science medical and health sciencesclinical medicineophthalmologystrabismus Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Topic(s) EIC-SMEInst-2018-2020 - SME instrument Call for proposal H2020-EIC-SMEInst-2018-2020 See other projects for this call Sub call H2020-SMEInst-2018-2020-2 Funding Scheme SME-2 - SME instrument phase 2 Coordinator REMMEDVR SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA Net EU contribution € 1 937 530,00 Address Domaniewska 41/10 02 672 Warszawa Poland See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Makroregion województwo mazowieckie Warszawski stołeczny Miasto Warszawa Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 830 370,00
